Tiziana Life Sciences annual current ratio
2017
2018
2019
2020
2021
2022
2023
2024
2025
Tiziana Life Sciences Current Ratio Growth & History (TLSA)
Tiziana Life Sciences's current ratio was 0.76 for fiscal 2025.
View full Tiziana Life Sciences company overviewTiziana Life Sciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.76 | −0.26 | −25.33% |
| 2024 | 2024-12-31 | 1.02 | −0.10 | −8.94% |
| 2023 | 2023-12-31 | 1.12 | −2.52 | −69.21% |
| 2022 | 2022-12-31 | 3.64 | −2.81 | −43.51% |
| 2021 | 2021-12-31 | 6.45 | −2.34 | −26.64% |
| 2020 | 2020-12-31 | 8.79 | 8.59 | +4195.32% |
| 2019 | 2019-12-31 | 0.20 | −0.88 | −81.04% |
| 2018 | 2018-12-31 | 1.08 | 0.56 | +109.51% |
| 2017 | 2017-12-31 | 0.52 | — | — |
Tiziana Life Sciences quarterly current ratio
Q4.17
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.76 | −0.26 | −25.33% |
| Q4 2024 | 2024-12-31 | 1.02 | −0.10 | −8.94% |
| Q4 2023 | 2023-12-31 | 1.12 | −2.52 | −69.21% |
| Q4 2022 | 2022-12-31 | 3.64 | −2.81 | −43.51% |
| Q4 2021 | 2021-12-31 | 6.45 | −2.34 | −26.64% |
| Q4 2020 | 2020-12-31 | 8.79 | 8.59 | +4195.32% |
| Q4 2019 | 2019-12-31 | 0.20 | −0.88 | −81.04% |
| Q4 2018 | 2018-12-31 | 1.08 | 0.56 | +109.51% |
| Q4 2017 | 2017-12-31 | 0.52 | — | — |
Tiziana Life Sciences current ratio trends
Over the last five fiscal years, Tiziana Life Sciences's current ratio decreased from 8.79 to 0.76, a change of −8.03. The latest reported quarter, Q4 2025, shows 0.76.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tiziana Life Sciences source filings ↗